Pharmacogenomics
What Is Pharmacogenomics and How Can It Support Personalised Medicine?
Pharmacogenomics is the study of how a person’s genetic variations influence their response to medicines. These differences can affect how the body processes a medicine, how it interacts with its intended target, and the likelihood of experiencing certain side effects. By examining relevant genetic information, pharmacogenomic testing can help healthcare professionals make more informed decisions about medication selection and, where supported by clinical evidence, dosing.
People can respond differently to the same medicine, even when it is prescribed for the same condition. In some cases, genetic variations contribute to these differences by influencing drug metabolism or sensitivity to treatment. Pharmacogenomics aims to use this information to support a more individualised approach to healthcare, rather than relying solely on general prescribing recommendations.
As part of personalised medicine, pharmacogenomics may help identify when a patient’s genetic profile is relevant to a particular medication. However, not every medicine has an established genetic association, and testing cannot predict every treatment outcome or eliminate the risk of adverse reactions. Age, other medical conditions, liver and kidney function, lifestyle and interactions with other medicines can also influence treatment response.
The clinical value of pharmacogenomic testing therefore depends on the medicine being considered, the strength of the available evidence and the patient’s individual circumstances. When interpreted alongside other clinical information, genetic results can provide an additional source of evidence to help healthcare professionals assess appropriate treatment options.
How Do Genetic Differences Influence Medication Response?
Genetic variations can influence how the body absorbs, processes and responds to medicines. These differences may affect how quickly a medicine is broken down, how much of it reaches its target, or how the target itself responds to treatment.
Drug Metabolism and Enzymes
Some genes provide instructions for enzymes that break down medicines. Variations in these genes can cause a medicine to be metabolised more slowly or quickly than expected, potentially affecting its concentration in the body.
For example, CYP2C19 variations can influence how the body activates clopidogrel, an antiplatelet medicine. Some genetic variants are associated with reduced activation and a lower antiplatelet response.
Drug Transport and Targets
Other genes influence proteins that transport medicines into or out of cells, or determine how medicines interact with their biological targets. These differences can affect drug exposure or treatment response.
For example, SLCO1B1 variations can influence the transport of simvastatin into the liver and are associated with an increased risk of muscle-related side effects in some patients.
Understanding these genetic differences can help healthcare professionals interpret a person’s likely response to certain medicines. However, genetic information is only one part of treatment decisions and must be considered alongside clinical factors and current prescribing guidance.
What Can Pharmacogenomic Testing Help Assess?
Pharmacogenomic testing examines genetic variations that may influence how a person responds to certain medicines. Depending on the medicine and the available clinical evidence, results may help healthcare professionals assess drug metabolism, treatment response and the risk of specific adverse effects.
| Assessment Area | What It May Reveal | Example |
|---|---|---|
| Drug Metabolism | Whether genetic variations may affect how quickly a medicine is processed or activated. | CYP2C19 and clopidogrel activation. |
| Treatment Response | Whether a genetic variant is associated with a reduced or altered response to a particular medicine. | CYP2C19 variants associated with reduced response to clopidogrel. |
| Adverse Effect Risk | Whether certain genetic variants are associated with an increased risk of specific medicine-related side effects. | SLCO1B1 variants and simvastatin-related muscle effects. |
| Dose Guidance | Whether genetic information supports a different starting dose or dosing approach for a medicine. | CYP2C9 and VKORC1 variants can inform warfarin dosing alongside clinical factors. |
Genetic results are one part of medication assessment. Their usefulness depends on the medicine, the strength of the evidence and the individual's clinical circumstances. A healthcare professional should interpret the findings alongside other relevant information before making treatment decisions.
Pharmacogenetics Test
Analyses genetic variations that influence how an individual metabolises and responds to different medications. This test helps healthcare providers optimise drug selection and dosing, reducing adverse effects and improving treatment efficacy. It is particularly useful for tailoring treatments in various medical fields.-
Analyses genetic variations that influence drug metabolism and response.
-
Helps healthcare providers optimise drug selection and dosing.
-
Crucial for reducing adverse effects and improving treatment efficacy.
-
Particularly useful for tailoring treatments in various medical fields (e.g., oncology, psychiatry).
-
Supports personalised medicine by ensuring the right dose for the right patient.
-
Provides essential information to avoid drugs that may be ineffective or harmful.
Which Factors Affect the Interpretation of Pharmacogenomic Results?
Genetic findings are only one part of understanding how a medicine may affect an individual. The same genetic profile can have different clinical implications depending on a person’s health, other treatments and the specific medicine being considered.
Key Factors Beyond Genetics
- Other medicines: Some medicines can alter the activity of drug-metabolising enzymes, potentially changing how another medicine is processed.
- Liver and kidney function: These organs help process or eliminate many medicines, so impaired function may affect drug exposure and safety.
- Existing health conditions: The condition being treated and other medical problems can influence which medicines are appropriate.
- Age and lifestyle: Factors such as age, smoking and dietary habits may affect the response to certain medicines.
- Clinical evidence: The usefulness of a genetic finding depends on whether a reliable association has been established for the specific medicine and treatment context.
For this reason, pharmacogenomic findings should be interpreted alongside a person’s medication history and current clinical information. A genetic result may inform a prescribing decision, but it does not independently determine the most suitable medicine or guarantee a particular treatment outcome.
Who May Benefit from Pharmacogenomic Testing?
Pharmacogenomic testing may be worth considering when genetic information could help guide the use of a specific medicine. Its suitability depends on the medication, the available clinical evidence and the individual’s medical circumstances.
When Might Testing Be Considered?
- Unexpected treatment response: People who have experienced limited benefit from a medicine when a well-established gene–drug association may be relevant.
- Medication-related side effects: Individuals who have experienced adverse reactions to certain medicines, where genetic testing could help inform future prescribing decisions.
- Before starting certain medicines: Testing may be recommended before treatment when established clinical guidance supports using genetic information to guide prescribing.
- Complex medication needs: People taking multiple medicines may benefit in selected circumstances, particularly when a specific gene–drug interaction is clinically relevant.
Pharmacogenomic testing is not necessary for every patient or every medicine. A healthcare professional can assess whether a relevant test is available, whether its results are likely to influence treatment decisions and how the findings should be interpreted alongside other clinical information.
How Does Pharmacogenomic Testing Work?
Pharmacogenomic testing follows a series of steps to assess whether genetic information may help guide the use of certain medicines. The process depends on the clinical question, the test selected and the information required.
Clinical Assessment and Test Selection
A healthcare professional reviews the person's medical history, current medicines and the clinical question to determine whether pharmacogenomic testing may be appropriate.
Sample Collection
A suitable biological sample, such as a cheek swab or blood sample, is collected according to the requirements of the selected test.
Genetic Analysis
The sample is analysed for relevant genetic variations that may influence how the body processes or responds to particular medicines.
Interpretation of Results
Identified variants are interpreted in the context of available scientific evidence and relevant guidance for the medicines being considered.
Clinical Review and Treatment Decisions
Results are reviewed alongside the person's health, medication history and other clinical factors to assess whether they may inform medicine selection or dosing.
Pharmacogenomic results support clinical decision-making; they do not replace it. Whether testing influences treatment depends on the medicine involved, the strength of the evidence and the individual's circumstances. Results should be interpreted by an appropriately qualified healthcare professional.
What Do Pharmacogenomic Test Results Mean for Your Treatment?
Pharmacogenomic test results can provide information about how genetic variations may influence your response to certain medicines. When supported by established clinical evidence, these findings may help healthcare professionals evaluate treatment options, consider potential adverse effects or assess whether a different dosing approach may be appropriate.
How Can Results Inform Treatment Decisions?
Your healthcare professional can review the findings alongside your symptoms, medical history, current medicines and previous treatment responses. Depending on the medicine and the evidence available, the results may help to:
- Compare treatment options: identify genetic factors that may be relevant when considering medicines with different response or safety profiles.
- Review potential side effects: assess whether a genetic finding is associated with an increased risk of a specific medicine-related adverse effect.
- Consider dosing guidance: determine whether established recommendations support an adjustment to the starting dose or dosing approach.
- Support future prescribing decisions: provide relevant information that may be useful when reviewing certain medicines in the future.
A pharmacogenomic result is not a prescription and does not automatically mean that a medicine should be changed or that its dose needs adjusting. The clinical significance of each finding depends on the medicine, the strength of the evidence and the individual’s circumstances. Any treatment changes should be discussed with the prescribing healthcare professional.
Which Pharmacogenomics Services Are Available?
Pharmacogenomics services address different questions about how genetic variations may influence medication use. Explore the available services to find the area most relevant to your needs.
Explore how genetic information may help inform the use of selected medicines.
Learn how pharmacogenomic findings may inform prescribing decisions involving certain psychiatric medicines.
Discover how genetic factors may influence response to selected cardiovascular medicines.
Explore the role of pharmacogenomic information in the use of certain cancer medicines.
Understand how genetic findings may contribute to dosing decisions when supported by clinical evidence.
Not sure which pharmacogenomics service is right for you? A healthcare professional can help assess your circumstances and determine whether genetic testing may be relevant to your medication-related questions.
What Are the Benefits and Limitations of Pharmacogenomic Testing?
Pharmacogenomic testing can provide useful information about how genetic variations may influence responses to certain medicines. However, its clinical value varies by medicine, the strength of the available evidence and individual circumstances.
| Aspect | Potential Benefits | Limitations |
|---|---|---|
| Treatment Decisions | May help inform the choice between certain medicines when relevant gene–drug evidence is established. | Genetic findings do not identify the best treatment in every case or guarantee a positive response. |
| Dosing and Safety | May support dose guidance or help assess the risk of specific medicine-related adverse effects. | Testing cannot predict or prevent every adverse reaction, and any dose adjustment requires clinical assessment. |
| Scientific Evidence | For certain medicines, well-established gene–drug associations can support evidence-based prescribing decisions. | The strength and clinical usefulness of evidence vary. Some genetic findings have limited or uncertain relevance to treatment. |
| Medicines Covered | A suitable test may examine genetic variations relevant to one or more medicines, depending on its scope. | No single test covers every medicine or every genetic factor that may influence medication response. |
| Individual Health Factors | Results can add genetic information to a broader review of a person's treatment options. | Other medicines, health conditions, liver and kidney function, age and lifestyle can also affect drug response. |
Pharmacogenomic testing is a decision-support tool, not a guarantee of treatment success. Its usefulness depends on the medicine being considered, the evidence supporting the relevant genetic association and the individual's clinical circumstances. Results should be interpreted by an appropriately qualified healthcare professional alongside other relevant information.
What Should You Consider Before Having a Pharmacogenomic Test?
Before having a pharmacogenomic test, it is important to understand what the test is intended to assess and whether the results are likely to be relevant to your treatment. Considering the following points can help you make an informed decision with your healthcare professional.
Understand the Purpose and Scope of the Test
Start by identifying the medicine-related question the test is intended to address. Check which genes and genetic variations the test examines, which medicines its results may be relevant to and whether the findings could influence a clinical decision. A broader testing panel does not necessarily provide more useful information for every individual.
Check Costs and Availability
Testing costs, availability and eligibility may vary depending on the provider, the type of test and the clinical setting. Before proceeding, ask about the total cost, what the service includes, how long results may take and whether any additional consultation or interpretation fees apply.
Consider Genetic Data Privacy
Genetic information is personal data, so it is worth understanding how your sample and results will be stored, accessed and used. Ask who may receive the results, how long the information will be retained and whether it may be used for purposes beyond your immediate care. Review the provider’s privacy policy and consent arrangements before sharing your genetic information.
Plan for Clinical Interpretation
A test report may contain findings that require specialist interpretation. Ask who will explain the results and how they may relate to your current medicines and medical history. Genetic counselling may help you understand relevant genetic information, its limitations and the questions to discuss with your healthcare professional. Results should be considered alongside other clinical factors and relevant prescribing guidance, rather than used in isolation.
Do not start, stop or change a medicine or its dose solely on the basis of a genetic test result. Discuss any proposed treatment changes with the healthcare professional responsible for your care.
Do pharmacogenomic test results change over time?
Your genetic variants generally remain the same throughout your life. However, the scientific understanding of how particular variants affect medication response can evolve as new evidence becomes available. A previous result may therefore need to be reviewed if prescribing guidance or the interpretation of a genetic finding changes.
How is pharmacogenomic testing different from other genetic tests?
Pharmacogenomic testing focuses on genetic variations that may influence how a person processes or responds to certain medicines. Other genetic tests may investigate inherited conditions, disease susceptibility, reproductive risks or other health-related questions. The purpose and interpretation depend on the type of test being performed.
Does pharmacogenomic testing cover all medicines?
No. The genes and medicines covered depend on the specific test or panel. Not every medicine has an established, clinically useful gene–drug association, and a test may not examine every genetic variation relevant to medication response. The scope of the test should be checked before testing.
Will my medication definitely change after pharmacogenomic testing?
No. A test result does not automatically mean that your medicine or dose needs to change. Depending on the medicine and the strength of the available evidence, the results may support a prescribing decision, confirm that the current approach remains appropriate or have limited clinical relevance. Any treatment changes should be made in consultation with your healthcare professional.
Can pharmacogenomic testing predict whether a medicine will work for me?
Pharmacogenomic testing may provide information about genetic factors associated with medication response, but it cannot reliably predict every individual’s treatment outcome. The effectiveness and safety of a medicine can also depend on factors such as other medications, medical conditions, age and lifestyle.
Can I use my pharmacogenomic results for future prescriptions?
Potentially, yes. Because genetic variants generally remain stable throughout life, results may be relevant when considering certain medicines in the future. However, their usefulness depends on the medicines involved, the test’s scope and current clinical guidance. Keep a copy of your report and share it with your healthcare professional when relevant.
Discuss Pharmacogenomic Testing with Our Team
If you are considering pharmacogenomic testing, a consultation can help explore whether genetic testing may be relevant to your medication-related questions and individual circumstances.
Understanding the purpose of testing, the medicines covered and the clinical relevance of potential findings can help you make an informed decision about your next steps.
Not sure whether pharmacogenomic testing is suitable for you? Arrange a consultation with London Genetics to discuss your circumstances and explore the available options. Testing may provide useful information, but it cannot guarantee a particular treatment response or eliminate the risk of adverse effects.
Book a Consultation
I’ve been on psychiatric meds for years and always had side effects. Can this test actually save me from the usual trial and error?
Yes, Markus. By checking your genetic profile, we can often predict how you’ll react to certain meds. That way, we can avoid the long guesswork and get you on the right treatment faster.
I just had my pharmacogenomic test done here and I’m a bit nervous. Can it really help me know which antidepressant will work best?
Absolutely, Hannah. These tests look at your genes to see how your body might respond to different antidepressants. It’s not magic, but it really helps us choose the right medication and dose for you, so side effects are less likely.
How long does it usually take to get the test results?
Typically about 1–3 weeks, Layla. Once the results are in, we’ll go through them together and adjust your treatment accordingly. It’s quick and really useful for personalised care.